Vinorelbine (VNR) by alternating intravenous (IV)/oral administration plus cisplatinum (CP) followed by oral VNR as first-line therapy of advanced non-small cell lung cancer (ANSCLC)

被引：0
|
作者：
Sperandi, Francesca
Melotti, Barbara
Giaquinta, Stefania
Piana, Edera
Pavesi, Lorenzo
Da Prada, Gian Antonio
Lelli, Giorgio
Martoni, Andrea Angelo
机构：
[1] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[2] S Maugeri Fdn, Pavia, Italy
[3] Arcispedale St Anna, Ferrara, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] PHASE II TRIAL OF METRONOMIC ORAL VINORELBINE AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (MOVE TRIAL)
    Camerini, A.
    Puccetti, C.
    Donati, S.
    Valsuani, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [32] Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
    Tan, Eng Huat
    Tan, Daniel Shao Weng
    Li, Wen Yun
    Haaland, Benjamin
    Ang, Mei Kim
    Chau, Noan Min
    Toh, Chee Keong
    Tan, Lain Bee Huat
    Koh, Tong San
    Thng, Choon Hua
    Chowbay, Balram
    Hui, Kam Man
    Lim, Wan Teck
    Ng, Quan Sing
    LUNG CANCER, 2015, 88 (03) : 289 - 296
  • [33] Phase II trial of docetaxel and gefitinib as first-line therapy for elderly patients with advanced non-small cell lung cancer (ANSCLC).
    Williams, CC
    Haura, EB
    Antonia, SJ
    Chiappori, A
    Bepler, G
    Simon, GR
    Moffitt, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 701S - 701S
  • [34] FIRST-LINE CISPLATIN (P) WITH DOCETAXEL (TXT) OR VINORELBINE (VNR) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER: A PHASE II RANDOMIZED TRIAL OF GRUPPO ONCOLOGICO ITALIA MERIDIONALE
    Gebbia, V.
    Lorusso, V.
    Galetta, D.
    Caruso, M.
    Maiello, E.
    Riccardi, F.
    Carrozza, F.
    Borsellino, N.
    Leo, S.
    Ferrau, F.
    Cinieri, S.
    Colucci, G.
    EJC SUPPLEMENTS, 2008, 6 (14): : 151 - 151
  • [35] Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
    Dediu, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1345 - 1347
  • [36] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
  • [37] Cisplatin (CDDP) plus oral vinorelbine (NVBO) as first-line treatment for advanced non-small cell lung cancer (NSCLC): Prospective analysis to improve the patient's convenience on day 8 NVBO administration
    Sanchez, A.
    Provencio, M.
    Artal, A.
    Constenla, M.
    Garcia-Gomez, R.
    Vinolas, N.
    Domine, M.
    Perez, F. J.
    Gayo, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Cisplatin (CDDP) plus oral vinorelbine (NVBO) as first-line treatment for advanced non-small cell lung cancer (NSCLC): Prospective analysis to improve the patient's convenience on day 8 NVBO administration
    Provencio-Pulla, M.
    Sanchez-Hernandez, A.
    Domine, M.
    Artal, A.
    Garcia-Gomez, R.
    Constenla, M.
    Vinolas, N.
    De Castro, J.
    Sanchez, J. M.
    Perez, F. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
    Andrea Camerini
    Cheti Puccetti
    Sara Donati
    Chiara Valsuani
    Maria Cristina Petrella
    Gianna Tartarelli
    Paolo Puccinelli
    Domenico Amoroso
    BMC Cancer, 15
  • [40] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
    Camerini, Andrea
    Puccetti, Cheti
    Donati, Sara
    Valsuani, Chiara
    Petrella, Maria Cristina
    Tartarelli, Gianna
    Puccinelli, Paolo
    Amoroso, Domenico
    BMC CANCER, 2015, 15
12345